GSK plc (GSK) ORD GBP0.3125
2.50p
(0.14%)
- Add to watchlist
- Create an alert
- This stock can be held in a
2.50p
(0.14%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
2.50p
(0.14%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Share news, reports & tips
-
GSK posts better-than-expected Q3, upgrades guidance
29 October 2025 07:20
(Sharecast News) - GSK raised its full-year guidance on Wednesday, after delivering stronger-than-expected third-quarter results, driven by robust growth in specialty medicines and steady contributions from...
-
GSK lung cancer treatment gets EU orphan drug status
28 October 2025 07:14
(Sharecast News) - GSK on Tuesday said its treatment for small-cell lung cancer (SCLC) had received orphan drug status from the European Medicines Agency.
-
GSK shares lift on £268m prostate cancer deal
27 October 2025 09:33
(Sharecast News) - GSK shares lifted on Monday after the pharmaceutical giant signed a £268m deal with French biotech Syndivia for a potential treatment for prostate cancer.
-
GSK's Blenrep receives US FDA approval
24 October 2025 07:03
(Sharecast News) - Drugmaker GSK said on Friday that the US Food and Drug Administration had approved its Blenrep asset in combination with bortezomib and dexamethasone for the treatment of adults with...
-
GSK advances low-carbon inhaler, halts latozinemab study after mixed data
22 October 2025 08:12
(Sharecast News) - Drugmaker GSK released two sets of trial data on Wednesday, covering its low-carbon asthma inhaler and a potential new treatment for multiple sclerosis.
-
GSK reports positive trial data for oral cUTI treatment, secures EU backing for simplified shingles vaccine
21 October 2025 07:13
(Sharecast News) - Drugmaker GSK made two key updates on Monday, with positive phase III trial results for tebipenem HBr, an investigational oral antibiotic for complicated urinary tract infections, and a...
-
GSK shingles vaccine approved for expanded use in China
14 October 2025 07:07
(Sharecast News) - Pharma giant GSK has received regulatory approval in China to expand the use of its Shingrix shingles vaccine, the company announced on Tuesday.
-
London midday: UK stocks keep grinding towards year's highs
3 October 2025 11:15
(Sharecast News) - Stocks are moving higher still shortly before midday with investor sentiment buoyed by fresh bullish news around the artificial intelligence space, even as investors keep a wary eye on the...
-
Emma Walmsley to step down as chief executive of GSK
29 September 2025 07:01
(Sharecast News) - Chief executive Emma Walmsley is to leave GSK, it was announced on Monday, after nearly a decade in the role.
-
Trump to impose tariffs of 100% on branded drug imports
26 September 2025 07:53
(Sharecast News) - Donald Trump is to impose tariffs of 100% on imports of pharmaceutical goods, it emerged on Friday, the latest salvo in the US president's global trade war.
-
GSK plans $30bn US investment as pharma faces tariff threat
17 September 2025 07:03
(Sharecast News) - GSK has announced plans to invest $30bn across the US in research and development and supply chain infrastructure over the next five years, amid fears of tariffs being imposed on the...
-
GSK gepotidacin edges closer to landmark approval for gonorrhoea
11 August 2025 07:15
(Sharecast News) - Drugmaker GSK moved closer to expanding its antibiotic portfolio on Monday, after US regulators accepted its application to review gepotidacin as a potential oral treatment for gonorrhoea.
Company announcements Announcements
-
Transaction in Own Shares
31 October 2025 07:00
GSK
-
Director/PDMR Shareholding
30 October 2025 15:30
GSK
-
Transaction in Own Shares
30 October 2025 07:00
GSK
-
Transaction in Own Shares
29 October 2025 07:05
GSK
-
3rd Quarter Results
29 October 2025 07:00
GSK
-
Transaction in Own Shares
28 October 2025 07:00
GSK
-
GSK ADC gets orphan drug designation in the EU
28 October 2025 07:00
GSK
-
Transaction in Own Shares
27 October 2025 07:00
GSK
-
Blenrep approved by US FDA in multiple myeloma
24 October 2025 07:00
GSK
-
Transaction in Own Shares
24 October 2025 07:00
GSK
-
Transaction in Own Shares
23 October 2025 07:00
GSK
-
Positive data for low carbon version Ventolin MDI
22 October 2025 07:05
GSK
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2025. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.